Zydus Wellness Ltd

Zydus Wellness Ltd

₹ 1,997 4.08%
03 Jul 11:02 a.m.
About

Zydus Wellness operates as an integrated consumer Company with business encompassing the entire value chain in the development, production, marketing and distribution of health and wellness products. The product portfolio of the Company includes brands like Sugar free, Everyuth and Nutralite.(Source : 202003 Annual Report Page No: 83)

Key Points

Product Portfolio
The Company’s product portfolio includes brands like Glucon-D, Complan, Sugar-Free, Nycil, Everyuth, and Nutralite offering products such as Glucose Powder, Face wash, Scrub, Peel-Off, Face masks, Sugar Substitute, Blended Sugar, etc [1]

  • Market Cap 12,710 Cr.
  • Current Price 1,997
  • High / Low 1,999 / 1,425
  • Stock P/E 377
  • Book Value 634
  • Dividend Yield 0.26 %
  • ROCE 1.17 %
  • ROE 0.84 %
  • Face Value 10.0

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 131%

Cons

  • Stock is trading at 3.03 times its book value
  • Company has a low return on equity of 0.93% over last 3 years.
  • Earnings include an other income of Rs.18.0 Cr.
  • Working capital days have increased from 103 days to 145 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: FMCG Industry: Food - Processing - Indian

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
42.18 32.58 52.38 70.86 60.43 61.70 67.10 63.60 58.80 60.10 57.80 63.80 63.10
56.57 46.88 57.14 60.76 56.79 56.30 54.60 51.20 50.80 52.90 50.30 53.00 55.60
Operating Profit -14.39 -14.30 -4.76 10.10 3.64 5.40 12.50 12.40 8.00 7.20 7.50 10.80 7.50
OPM % -34.12% -43.89% -9.09% 14.25% 6.02% 8.75% 18.63% 19.50% 13.61% 11.98% 12.98% 16.93% 11.89%
5.58 4.22 3.93 3.70 3.55 3.70 2.90 3.30 3.60 4.10 4.60 4.60 4.70
Interest 0.28 0.49 0.50 0.54 0.49 0.40 0.00 0.60 0.10 0.00 0.80 0.90 0.90
Depreciation 0.87 0.68 0.69 0.70 0.77 0.70 1.10 0.70 1.00 0.90 0.90 0.90 0.90
Profit before tax -9.96 -11.25 -2.02 12.56 5.93 8.00 14.30 14.40 10.50 10.40 10.40 13.60 10.40
Tax % 0.00% 0.00% 0.00% 0.00% -126.14% 0.00% -3.50% -4.17% -173.33% 21.15% 25.00% 24.26% 28.85%
-9.96 -11.25 -2.02 12.56 13.41 8.00 14.80 15.00 28.70 8.20 7.80 10.30 7.40
EPS in Rs -1.57 -1.77 -0.32 1.97 2.11 1.26 2.33 2.36 4.51 1.29 1.23 1.62 1.16
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
213 203 219 200 225 264 255 153 114 216 251 245
125 122 126 122 137 152 182 174 164 222 213 212
Operating Profit 88 81 93 78 88 112 72 -21 -50 -5 38 33
OPM % 41% 40% 42% 39% 39% 42% 28% -14% -44% -2% 15% 13%
14 12 20 30 25 28 57 109 -60 15 13 18
Interest 0 0 0 0 0 2 30 140 75 2 1 3
Depreciation 2 2 5 4 4 4 3 3 3 3 4 4
Profit before tax 99 91 109 104 109 134 97 -55 -188 5 47 45
Tax % 2% -6% -0% 1% -1% 0% 1% 26% 3% -143% -41% 25%
97 96 109 103 109 134 96 -41 -182 13 66 34
EPS in Rs 24.85 24.69 27.88 26.43 27.98 34.24 16.70 -7.06 -28.62 2.00 10.44 5.30
Dividend Payout % 24% 24% 22% 25% 23% 23% 30% -71% -17% 251% 48% 94%
Compounded Sales Growth
10 Years: 2%
5 Years: -1%
3 Years: 29%
TTM: -3%
Compounded Profit Growth
10 Years: -10%
5 Years: -17%
3 Years: 38%
TTM: -49%
Stock Price CAGR
10 Years: 12%
5 Years: 7%
3 Years: -4%
1 Year: 30%
Return on Equity
10 Years: 2%
5 Years: 0%
3 Years: 1%
Last Year: 1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 39 39 39 39 39 39 58 58 64 64 64 64
Reserves 217 286 367 440 518 652 3,268 3,157 3,956 3,937 3,971 3,972
0 0 0 0 25 25 1,566 1,516 50 46 0 51
49 48 45 19 23 23 62 72 47 44 32 29
Total Liabilities 306 373 451 498 605 739 4,954 4,803 4,116 4,090 4,067 4,116
51 53 44 43 40 38 37 43 44 45 55 54
CWIP 0 0 0 0 0 0 1 1 1 2 0 4
Investments 96 146 100 209 254 294 3,690 3,528 3,671 3,683 3,698 3,676
158 175 306 245 310 407 1,226 1,231 400 360 314 382
Total Assets 306 373 451 498 605 739 4,954 4,803 4,116 4,090 4,067 4,116

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
77 88 89 79 88 113 86 -20 -52 -16 37 26
-35 -42 70 -19 -78 -109 -4,131 267 816 39 1 -47
-23 -27 -27 -58 -6 -2 4,049 -260 -710 -38 -79 15
Net Cash Flow 19 18 131 1 4 2 4 -13 54 -15 -42 -6

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 1 0 1 0 1 1 9 1 5 19 4 12
Inventory Days 44 34 25 23 38 32 24 57 67 22 20 23
Days Payable 99 94 58 71 93 84 106 151 158 75 44 45
Cash Conversion Cycle -55 -60 -32 -48 -55 -50 -73 -93 -85 -34 -20 -10
Working Capital Days -64 -71 -63 -23 -20 -16 -8 -26 15 19 144 145
ROCE % 45% 31% 30% 23% 21% 21% 4% 2% 0% 0% 1%

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
64.82% 64.82% 64.82% 64.82% 65.14% 65.36% 65.36% 66.45% 67.11% 68.54% 69.15% 69.62%
2.96% 2.94% 3.39% 2.56% 2.38% 3.24% 3.83% 3.87% 3.23% 3.42% 3.25% 3.26%
24.76% 25.49% 24.80% 25.11% 25.11% 23.78% 23.35% 22.18% 22.04% 20.22% 19.67% 19.41%
7.46% 6.75% 6.99% 7.51% 7.37% 7.62% 7.46% 7.51% 7.62% 7.81% 7.91% 7.71%
No. of Shareholders 58,03555,51359,82367,20866,84570,70968,96970,79073,02976,59075,36969,138

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls